← Open Payments lookup

MUKESH SANGHADIA: Open Payments

NPI 1366550246 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$17,023 in 26 payments from 7 companies in 2025. Trend: 2023 $23,372 · 2024 $45,493 · 2025 $17,023

Speaker / faculty: $10,940Consulting: $5,060Food & beverage: $985Travel & lodging: $38
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$10,319
Teva Pharmaceuticals USA, Inc.6$6,325
Alkermes, Inc.1$121
Neurelis, Inc.1$118
Janssen Pharmaceuticals, Inc1$93
Vanda Pharmaceuticals Inc.1$26
Otsuka America Pharmaceutical, Inc.1$21

Products named: INGREZZA, UZEDY, AUSTEDO XR, LYBALVI, VALTOCO, INVEGA SUSTENNA, FANAPT, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.